Mirabegron EP impurity D is a distinct structural variant of the ฮฒ3-adrenoceptor agonist Mirabegron. Its unique molecular composition, featuring two sulfur atoms compared to the parent drug's single thiazole sulfur, alongside increased carbon (C26 vs C21), nitrogen (N6 vs N4), and oxygen (O3 vs O2) count, points to a complex chemical transformation product. This impurity likely originates from specific synthetic side reactions or degradation pathways, potentially involving dimerization, cyclization, or an adduct formation impacting the thiazole moiety, the ethanolamine side chain, or the phenyl ring. The molecule retains core functionalities characteristic of Mirabegron, albeit in a modified arrangement or conjugation. It serves as a critical reference standard for Mirabegron purity profiling via HPLC.
On RequestNC=1SC=C(N1)CC(=O)NC=1SC=C(N1)CC(=O)NC1=CC=C(C=C1)CCNC[C@@H](C1=CC=CC=C1)O
InChI=1S/C26H28N6O3S2/c27-25-30-20(15-36-25)12-24(35)32-26-31-21(16-37-26)13-23(34)29-19-8-6-17(7-9-19)10-11-28-14-22(33)18-4-2-1-3-5-18/h1-9,15-16,22,28,33H,10-14H2,(H2,27,30)(H,29,34)(H,31,32,35)/t22-/m0/s1
WCZUXPQHIGZAGI-QFIPXVFZSA-N